Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9972850 | 0.84 | TSHR (0.32) | TSHR | |
| SCHEMBL8663640 | 0.80 | MAPK1 (0.31) | — | |
| SCHEMBL6665862 | 0.78 | TP53 (0.38) | TSHR | |
| SCHEMBL11128872 | 0.78 | — | — | |
| SCHEMBL2310819 | 0.78 | TP53 (0.38) | TSHR | |
| SCHEMBL4311782 | 0.78 | TP53 (0.38) | TSHR | |
| SCHEMBL7095714 | 0.76 | LMNA (0.35) | TSHR | |
| SCHEMBL19483348 | 0.76 | — | — | |
| SCHEMBL13203577 | 0.76 | — | — | |
| SCHEMBL13538204 | 0.74 | SMN1; SMN2 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159504-A1 | 7- OR 8-HYDROXY-ISOQUINOLINE AND 7- OR 8-HYDROXY-QUINOLINE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD) | VERTEX PHARMACEUTICALS INCORPORATED | 2023-05-25 | — | — | US | disclosed |
| US-9670232-B2 | Molecular precursor compounds for zinc-group 13 mixed oxide materials | TRANSTRON SOLUTIONS LLC (US) | 2017-06-06 | — | — | US | disclosed |
| EP-3102541-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR INDIUM GALLIUM ZINC OXIDE MATERIALS | TRANSTRON SOLUTIONS LLC (US) | 2016-12-14 | — | — | EP | disclosed |
| US-9455142-B2 | Molecular precursor compounds for ABIGZO zinc-group 13 mixed oxide materials | TRANSTRON SOLUTIONS LLC (US) | 2016-09-27 | — | — | US | disclosed |
| US-9404002-B2 | Molecular precursor compounds for indium gallium zinc oxide materials | TRANSTRON SOLUTIONS LLC (US) | 2016-08-02 | — | — | US | disclosed |
| US-20150221506-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ABIGZO ZINC-GROUP 13 MIXED OXIDE MATERIALS | PRECURSOR ENERGETICS, INC. (US) | 2015-08-06 | — | — | US | disclosed |
| US-20150218190-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ZINC-GROUP 13 MIXED OXIDE MATERIALS | PRECURSOR ENERGETICS, INC. (US) | 2015-08-06 | — | — | US | disclosed |
| US-20150218400-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR INDIUM GALLIUM ZINC OXIDE MATERIALS | PRECURSOR ENERGETICS, INC. (US) | 2015-08-06 | — | — | US | disclosed |
| US-20150221771-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ABGZO ZINC-GROUP 13 MIXED OXIDE MATERIALS | PRECURSOR ENERGETICS, INC. (US) | 2015-08-06 | — | — | US | disclosed |
| US-20150221772-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ABIZO ZINC-GROUP 13 MIXED OXIDE MATERIALS | PRECURSOR ENERGETICS, INC. (US) | 2015-08-06 | — | — | US | disclosed |
| US-9011918-B2 | Biocompatible and biodegradable elastomeric polymers | EVONIK CORPORATION (US) | 2015-04-21 | — | — | US | disclosed |
| US-20120301518-A1 | BIOCOMPATIBLE AND BIODEGRADABLE ELASTOMERIC POLYMERS | EVONIK OPERATIONS GMBH (DE) | 2012-11-29 | — | — | US | disclosed |
| US-8246991-B2 | Biocompatible and biodegradable elastomeric polymers | SURMODICS PHARMACEUTICALS, INC. (US) | 2012-08-21 | — | — | US | disclosed |
| US-20100003305-A1 | BIOCOMPATIBLE AND BIODEGRADABLE ELASTOMERIC POLYMERS | EVONIK OPERATIONS GMBH (DE) | 2010-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120301518-A1 | BIOCOMPATIBLE AND BIODEGRADABLE ELASTOMERIC POLYMERS | ECPAS, FN1, DDR1 | TSHR 3155/4885 |
| US-20150218400-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR INDIUM GALLIUM ZINC OXIDE MATERIALS | IKZF3, ZFR, IGSF11 | TSHR 2105/4885 |
| US-20150221506-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ABIGZO ZINC-GROUP 13 MIXED OXIDE MATERIALS | AOC3, ZRANB2, AOC2 | TSHR 4083/4885 |
| US-20150221772-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ABIZO ZINC-GROUP 13 MIXED OXIDE MATERIALS | IKZF3, ZRANB2, ZFR | TSHR 3832/4885 |
| US-20100003305-A1 | BIOCOMPATIBLE AND BIODEGRADABLE ELASTOMERIC POLYMERS | ECPAS, FN1, DDR1 | TSHR 3155/4885 |
| US-20150221771-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ABGZO ZINC-GROUP 13 MIXED OXIDE MATERIALS | ZFR, IKZF3, SLC39A11 | TSHR 4379/4885 |
| US-20230159504-A1 | 7- OR 8-HYDROXY-ISOQUINOLINE AND 7- OR 8-HYDROXY-QUINOLINE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD) | SERPINA2, SERPINB1, SERPINE1 | TSHR 2764/4885 |
| US-20150218190-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ZINC-GROUP 13 MIXED OXIDE MATERIALS | ZFR, ZRANB2, IKZF3 | TSHR 3366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.